Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
11 hedge funds and large institutions have $7.73M invested in Aptose Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
14% more capital invested
Capital invested by funds: $6.77M → $7.73M (+$967K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.96K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.39K |
| 3 |
Morgan Stanley
New York
|
+$1.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$14.3K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.77K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.39K |
| 4 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$1.01K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $4.17M | – | – | – |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $3.18M | – | – | – |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $159K | -$4.77K | -4 | -3% |
|
|
BBA
4
Baker Bros. Advisors
New York
| $100K | – | – | – |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $42K | -$14.3K | -12 | -27% |
|
|
CC
6
Callan Capital
La Jolla,
California
| $36K | – | – | – |
|
|
KCM
7
Knoll Capital Management
Miami,
Florida
| $34K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $8K | +$5.96K | +5 | +500% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $3K | +$2.39K | +2 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $2K | -$2.39K | -2 | -50% |
|
|
11
Morgan Stanley
New York
| $2K | +$1.19K | +1 | +100% |
|
|
SIM
12
Sonora Investment Management
Tucson,
Arizona
| $20 | – | – | – |
|
|
PAIM
13
Punch & Associates Investment Management
Edina,
Minnesota
| – | -$1.01K | -1 | Closed |
|
APTO Hedge Fund Activity: Q1 2016 in Review
11 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2016, worth a combined $7.73M — up 14% from $6.77M a quarter earlier.
Fund positioning in APTO was balanced in Q1 2016: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $5.96K. The largest seller was Royal Bank of Canada, cutting an estimated $14.3K.
- 11 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $7.73M of Aptose Biosciences, Inc. stock for Q1 2016, up 14% quarter-over-quarter.
- 1 fund opened new Aptose Biosciences, Inc. positions in Q1 2016 and 1 closed out, a net change of 0 holders.
- The largest Aptose Biosciences, Inc. buyer in Q1 2016 was UBS Group, an estimated $5.96K added.
- The largest Aptose Biosciences, Inc. seller in Q1 2016 was Royal Bank of Canada, an estimated $14.3K sold.
Based on aggregated 13F filings for Q1 2016.